Tradestie Institutional Equity Comparison Engine
NVS vs PFE โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
NVS Overall Edge
NVS Captures Institutional Edge (4โ0 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Novartis AG (NVS) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, NVS trades at 16.1x Forward P/E with 34.0% operating margin (+4.7% YoY revenue) versus PFE at 9.8x Forward P/E and 29.1% operating margin (-0.4% YoY). In options structure, NVS sits in UNCLASSIFIED (6th %ile IV; Dealer Gamma Walls on Pro) against PFE sits in CONSOLIDATION (33rd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
NVS
NVS 16.1x vs PFE 9.8x Fwd P/E
Growth & Margin Winner
NVS
Op Margin 34.0% vs 29.1% ยท YoY +4.7% vs -0.4%
Momentum & Technical Winner
NVS
1Y +21.3% vs +13.5% ยท 52W Pos 76% vs 62%
Options & Structure Winner
NVS
UNCLASSIFIED (6th %ile IV) vs CONSOLIDATION (33rd %ile IV)
NVS
NYSE
Novartis AG
Pharmaceutical Preparations
$159.20
-0.62% 1D
Market Cap
$303.1B
1M Return
+5.99%
1Y Return
+21.29%
Forward P/E
16.1x
Unified AI Score
42.2 / 100
HOLD
Tech 33.0
Fund 38.0
Flow 50.0
Mom 31.1
PFE
NYSE
Pfizer Inc.
Pharmaceutical Preparations
$28.45
-1.42% 1D
Market Cap
$164.7B
1M Return
-3.36%
1Y Return
+13.53%
Forward P/E
9.8x
Unified AI Score
52.3 / 100
HOLD
Tech 32.0
Fund 54.0
Flow 68.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
NVS +21.29%
PFE +13.53%
Spread: +7.76 pp (NVS Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
NVS TTM Op. Margin: 34.0%
PFE TTM Op. Margin: 29.1%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NVS vs PFE. Trailing 12-month operating profitability (NVS 34.0% vs PFE 29.1%) and valuation multiples (NVS 16.1x vs PFE 9.8x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NVS | PFE | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $303.1B | $164.7B | Larger Scale | NVS |
| Trailing P/E Ratio Valuation | 30.6x | 41.3x | Lower Multiple | NVS |
| Forward P/E Ratio Valuation | 16.1x | 9.8x | Lower Multiple | PFE |
| Revenue Growth (YoY) Growth | +4.7% | -0.4% | Higher Growth | NVS |
| Operating Margin (TTM) Profitability | 34.0% | 29.1% | Higher Margin | NVS |
| Net Profit Margin Profitability | 17.5% | 6.3% | Higher Margin | NVS |
| Return on Equity (ROE) Capital Efficiency | 24.3% | 4.5% | Higher ROE | NVS |
| 52-Week Range Position Momentum | 76% ($123โ$170) | 62% ($24โ$31) | Stronger Trend | NVS |
| Beta / 30D Volatility Risk Regime | 0.31ฮฒ ยท 26% Vol | 0.18ฮฒ ยท 24% Vol | Lower Realized Risk | PFE |
| Unified Institutional Score Composite Signal | 42.2 / 100 (HOLD) | 52.3 / 100 (HOLD) | Higher Composite | PFE |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full NVS vs PFE Buy Guide
NVS
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
6th %ile
IV Regime
Compressed (<25th %ile)
PFE
CONSOLIDATION
53d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
33rd %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither NVS nor PFE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.